Combination therapy with methotrexate in inflammatory bowel disease: time to COMMIT?
Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
Neeraj
N
Narula
Inserm U954 and Department of Hepato-Gastroenterology, Université de Lorraine, Vandœuvre-lès-Nancy, France.
Laurent
L
Peyrin-Biroulet
Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: jean-frederic.colombel@mssm.edu.
Jean-Frederic
JF
Colombel
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000069285:Infliximab; D008727:Methotrexate